Host Cell Protein Testing Market

Host Cell Protein Testing Market Size

The global host cell protein testing market size was estimated at USD 2.6 billion in 2025 and is projected to reach USD 5.6 billion by 2035, growing at a CAGR of 8.17% from 2025 to 2035.

Host Cell Proteins or HCPs are the process-associated protein contamination that are developed by the host bacterium in the course of biotherapeutic production and manufacturing. Most of the developed HCPs are eliminated from the finished product during the purification process (more than 99 percent impurities eliminated). HCP analysis is a technique to determine how much host cell protein is present in samples from drug material and downstream purification.

Market Highlights

The improvements in the biopharmaceutical domain as well as expanding R&D activities are expected to boost the growth of Host Cell Protein Testing Market over the forecast period.

Host Cell Protein Testing Market Segmentation

Mass Spectrometry-Based Assays segment is expected to dominate in the forecast period

Host Cell Protein Testing Market is classified based on the Testing Type into PCR-Based Assays, ELISA-Based Assays, Mass Spectrometry-Based Assays, and Others. The PCR-Based Assays segment dominated the market in the past years. Genetic material from a particular organism, including a virus, can be found using PCR-based techniques. These tests are generally used for the quick and accurate detection of infectious diseases including those brought on by viruses or bacteria. Anaerobic microorganisms, for example, are used to identify non-cultivable or slowly growing bacteria. However, the mass spectrometry-based assays category will be holding the largest rate of growth during the projection period. The growing prevalence of chronic diseases, as well as increased R&D funding for manufacturing novel diagnostic processes are projected to fuel segment growth.

Contract Research Organizations segment is expected to dominate in the forecast period

Host Cell Protein Testing Market is classified based on the End User into Contract Research Organizations, Biopharmaceutical Companies, Others. The Biopharmaceutical Companies category led the market in the previous years. This is attributed to the increased use of HCP testing in biopharmaceutical businesses. Biopharmaceutical medications are used to treat a wide range of disorders, including diabetes, cardiovascular disease, and cancer. Contract Research Organizations, on the other hand, is the fastest-growing sector, owing to the increased government financing for research operations.

Market Dynamics                                               

Growth Drivers

Growing Demand for Drugs Needed for Different Cancer Types and Ongoing R&D Activities are Expected to Boost the Market Growth

The increasing demand for medications to treat different cancer types and inflammatory ailments has compelled market participants to upgrade biopharmaceutical research centers and manufacturing units. Such demand is stimulating the growth of biopharmaceutical capabilities, which increased the volume of medication production even further. Furthermore, continued testing-related research and development activities, as well as an increasing number of governing approvals for testing equipment, will drive market growth.

Remarkable Technical Advancements are expected to Boost the Market Growth

The remarkable technical advancements in HCP testing equipment, with a great emphasis on uplifting their superiority and incorporating more features, would be beneficial to the global market. To acquire a larger saturation in the Host Cell Protein Testing Market, most suppliers are focusing on product and technological developments as well as acquiring clearance from authoritative bodies. These factors are projected to fuel the Host Cell Protein Testing Market in future.

Restraint

Growing Concerns Related to Immunogenesis is expected to Restrain the Market Growth

Concerns associated with immunogenesis is one of the major restraining factors of the Host Cell Protein Testing Market. Furthermore, issues with the accuracy and efficiency of the test kits, as well as long-term returns among consumers, may limit market expansion.

Recent Developments

• Mesa Biotech, Inc. was bought by Thermo Fisher Scientific Inc. in February 2021. The acquisition will accelerate Thermo Fisher's PCR-based assay expansion and broaden its products in the said market. Mesa Biotech created the Accula System, a low-cost and simple point-of-care PCR-based testing instrument for infectious disease identification.
• Charles River Laboratories International Incorporation launched first (ELISA) Enzyme-Linked Immunosorbent Assay Kit in Feb 2023 for quantification and identification of residual HCP in CHO bio-therapeutics. The specificity and sensitivity of Charles River's HCP ELISA kit are market-leading, triumphing 90% and 0.1 ng/mL antibody coverage. This rise in specificity and sensitivity is supported by the adoption of unique chicken immunoglobulin Y antibodies.

Host Cell Protein Testing Market Key Players Covered:

• Thermo Fisher Scientific Inc.
• Charles River Laboratories International Inc.
• Agilent
• PerkinElmer
• Sartorius AG
• Pall Corporation
• Bio-Rad Laboratories Inc.
• Abcam Plc
• Enzo Life Sciences Inc.
• Cygnus Technologies LLC
• Rockland Immunochemicals Inc.
• Cisbio Bioassays
• Prolytix
• Biogenes Gmbh
• Creative Proteomics
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Regional Analysis

Host Cell Protein Testing Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America is expected to registered a major share of the host cell protein testing market due to increased R&D investments, the presence of significant businesses, and the region's matured healthcare infrastructure. Europe is expected to account for a large part of the market due to supportive government initiatives and increased R&D spending. Asia-Pacific is expected to be the quickest-growing market throughout the projection period owing to the high prevalence of chronic diseases like cancer and expanding economies.

Impact of Covid-19 on Host Cell Protein Testing Market

The global spread of the lethal corona virus impeded commodity mobility across regions and continents. The virus outbreak had an effect on the overalls supply chain, starting from delivery of raw material to final goods transportation. A specific team of suppliers was organized to analyze the whole raw materials and finished products supply chain. During the epidemic, the special group was in charge of evaluating cross-border issues and trade limitations. Furthermore, in order to meet the standards, the manufacturers updated their transportation and packaging infrastructure.

Host Cell Protein Testing Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Host Cell Protein Testing Market Scope and Segments:

Frequently Asked Questions (FAQ):